Bio:

Nathan received his Ph.D. in Immunology and Clinical Science from the University of Cape Town, where he assessed the host immune response and antibiotic sensitivity in gene-specific knockouts of Mycobacterium tuberculosis. He then moved to the University of Washington for his postdoctoral training, where he worked on describing a cohort of people who seemingly “resist” tuberculosis in high-exposure settings, and helped to robustly identify key T cell populations that correlate with this resistance. Additionally, he worked on identifying and phenotyping lipid-specific primary human B-cells in the context of Mycobacterium tuberculosis infection. At the Allen Institute for Immunology, Nathan will investigate the role of CXCL16 and other key cytokines and chemokines in modulating antigen-specific T-cell responses and tissue organization, utilizing cutting-edge single-cell and spatial analysis technologies.